4 months Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks

   X     

4 months Tina Marriott Sells 6,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock MarketBeat

   X     

4 months Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Up 5.1% – Here’s What Happened MarketBeat

   X     

4 months Regeneron to Report Q3 Earnings: What’s in the Offing? Zacks

   X     

4 months Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% Higher – Time to Buy? MarketBeat

   X     

4 months Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up – What’s Next? MarketBeat

   X     

4 months Vivid Wealth Management LLC Purchases Shares of 4,352 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) MarketBeat

   X     

4 months Craig Hallum Raises Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00 MarketBeat

   X     

4 months EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up – Still a Buy? MarketBeat

   X     

4 months Corvus Pharmaceuticals (NASDAQ:CRVS) Reaches New 12-Month High – Time to Buy? MarketBeat

   X     

4 months BioCryst Pharmaceuticals (BCRX) to Release Earnings on Monday MarketBeat

   X     

4 months Supernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on Monday MarketBeat

   X     

4 months Assenagon Asset Management S.A. Raises Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) MarketBeat

   X     

4 months ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Assenagon Asset Management S.A. MarketBeat

   X     

4 months Madrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 Earnings Seeking Alpha

   X     

4 months Allspring Global Investments Holdings LLC Buys 29,465 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) MarketBeat

   X     

4 months Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Acquired by Allspring Global Investments Holdings LLC MarketBeat

   X     

4 months Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Average Rating of “Moderate Buy” by Brokerages MarketBeat

   X     

4 months Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts MarketBeat

   X     

4 months Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Short Interest Up 54.9% in October MarketBeat

   X     

4 months Short Interest in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Expands By 38.2% MarketBeat

   X     

4 months Alnylam Pharmaceuticals Q3 Earnings Preview: Key RNAi Catalysts To Watch Seeking Alpha

   X     

4 months Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Update MarketBeat

   X     

4 months Boston Trust Walden Corp Acquires Shares of 539,639 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) MarketBeat

   X     

4 months Mirae Asset Global Investments Co. Ltd. Sells 5,915 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) MarketBeat

   X     

4 months Brighton Jones LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) MarketBeat

   X     

4 months Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Rating of “Buy” by Analysts MarketBeat

   X     

4 months Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Sells $180,591.96 in Stock MarketBeat

   X     

4 months Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts MarketBeat

   X     

4 months Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Silver Oak Securities Incorporated MarketBeat

   X     

4 months E. Ohman J or Asset Management AB Invests $1.49 Million in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) MarketBeat

   X     

4 months Allspring Global Investments Holdings LLC Raises Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) MarketBeat

   X     

4 months Ionis Pharmaceuticals (NASDAQ:IONS) Rating Lowered to Sell at StockNews.com MarketBeat

   X     

4 months Insider Selling: Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Sells 11,742 Shares of Stock MarketBeat

   X     

4 months Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 6% – Should You Buy? MarketBeat

   X     

4 months NVS vs. LLY: Which Stock Is the Better Value Option? Zacks

   X     

4 months Warther Private Wealth LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) MarketBeat

   X     

4 months HC Wainwright Reaffirms “Buy” Rating for Rigel Pharmaceuticals (NASDAQ:RIGL) MarketBeat

   X     

4 months Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reiterated at HC Wainwright MarketBeat

   X     

4 months Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know Zacks

   X     

4 months Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 0.2% – Here’s Why MarketBeat

   X     

4 months Cipher Pharmaceuticals (TSE:CPH) PT Raised to C$19.00 at Stifel Nicolaus MarketBeat

   X     

4 months Equities Analysts Offer Predictions for TSE:CPH Q4 Earnings MarketBeat

   X     

4 months Olema Pharmaceuticals’ (OLMA) Buy Rating Reiterated at HC Wainwright MarketBeat

   X     

4 months Mizuho Upgrades Corvus Pharmaceuticals (NASDAQ:CRVS) to Strong-Buy MarketBeat

   X     

4 months Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated by Analysts at UBS Group MarketBeat

   X     

4 months Centessa Pharmaceuticals plc (NASDAQ:CNTA) CEO Sells $39,709.44 in Stock MarketBeat

   X     

4 months Corvus Pharmaceuticals (NASDAQ:CRVS) Lifted to “Hold” at StockNews.com MarketBeat

   X     

4 months Centessa Pharmaceuticals plc (NASDAQ:CNTA) CEO Saurabh Saha Sells 2,592 Shares MarketBeat

   X     

4 months Ionis Pharmaceuticals: Catalysts Due In 2025/2026 Are Extremely Compelling Seeking Alpha

   X